Micro-RNAs targeting the estrogen receptor alpha involved in endocrine therapy resistance in breast cancer

被引：0
|
作者：
Marquez-Mendoza, J. M. [2 ]
Baranda-Avila, N. [1 ]
Lizano, M. [1 ,3 ]
Langley, E. [1 ]
机构：
[1] Inst Nacl Cancerol, Unidad Invest Biomed Canc, Subdirecc Invest Bas, Mexico City 14080, Mexico
[2] Univ Nacl Autonoma Mexico, Programa Doctorado Ciencias Biomed, Inst Invest Biomed, Ciudad Univ, Mexico City 04510, Mexico
[3] Univ Nacl Autonoma Mexico, Dept Med Genom & Toxicol Ambiental, Inst Invest Biomed, Ciudad Univ, Mexico City 04510, Mexico
来源：
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE | 2025年 / 1871卷 / 05期
关键词：
Noncoding RNAs; micro-RNAs; Estrogen receptor alpha; Endocrine therapy resistance; Breast cancer; ENHANCES TAMOXIFEN RESISTANCE; ER-ALPHA; GENE-EXPRESSION; TRANSCRIPTIONAL REGULATION; DIFFERENTIAL EXPRESSION; ANTIESTROGEN RESISTANCE; PROTEIN EXPRESSION; MIR-221; PROMOTES; DRUG-RESISTANCE; DOWN-REGULATION;
D O I：
10.1016/j.bbadis.2025.167783
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Endocrine therapy resistance (ETR) in breast cancer (BC) is a multicausal phenomenon with diverse alterations in the tumor cell interactome. Within these alterations, non-coding RNAs (ncRNAs) such as micro-RNAs (miRNAs) modulate the expression of tumor suppressor genes and proto-oncogenes, such as the ESR1 gene encoding estrogen receptor alpha (ER alpha). This work aims to review the effects of miRNAs targeting ER alpha mRNA and their mechanisms related to ETR in BC. A thorough review of the literature and an in silico study were carried out to elucidate the involvement of each miRNA, thus contributing to the understanding of ETR in BC.
引用
收藏
页数：17
相关论文
共 50 条
  • [1] Long Noncoding RNAs Involved in the Endocrine Therapy Resistance of Breast Cancer
    Takeiwa, Toshihiko
    Ikeda, Kazuhiro
    Mitobe, Yuichi
    Horie-Inoue, Kuniko
    Inoue, Satoshi
    CANCERS, 2020, 12 (06)
  • [2] Micro-RNAs and breast cancer
    Le Quesne, John
    Caldas, Carlos
    MOLECULAR ONCOLOGY, 2010, 4 (03) : 230 - 241
  • [3] Targeting tyrosine-kinases and estrogen receptor abrogates resistance to endocrine therapy in breast cancer
    Liu, Shuying
    Meng, Xiaolong
    Chen, Huiqin
    Liu, Wenbin
    Miller, Todd
    Murph, Mandi
    Lu, Yiling
    Zhang, Fan
    Gagea, Mihai
    Arteaga, Carlos L.
    Mills, Gordon B.
    Meric-Bernstam, Funda
    Gonzalez-Angulo, Ana M.
    ONCOTARGET, 2014, 5 (19) : 9049 - 9064
  • [4] Non-Coding RNAs Modulating Estrogen Signaling and Response to Endocrine Therapy in Breast Cancer
    Treeck, Oliver
    Haerteis, Silke
    Ortmann, Olaf
    CANCERS, 2023, 15 (06)
  • [5] Endocrine resistance and epigenetic reprogramming in estrogen receptor positive breast cancer
    Dimitrakopoulos, Foteinos-Ioannis
    Kottorou, Anastasia
    Tzezou, Aspasia
    CANCER LETTERS, 2021, 517 : 55 - 65
  • [6] Endocrine therapy resistance in estrogen receptor (ER)-positive breast cancer
    De Marchi, Tommaso
    Foekens, John A.
    Umar, Arzu
    Martens, John W. M.
    DRUG DISCOVERY TODAY, 2016, 21 (07) : 1181 - 1188
  • [7] microRNA Regulation in Estrogen Receptor-Positive Breast Cancer and Endocrine Therapy
    Howard, Erin W.
    Yang, Xiaohe
    BIOLOGICAL PROCEDURES ONLINE, 2018, 20
  • [8] Most recent strategies targeting estrogen receptor alpha for the treatment of breast cancer
    Kumar, Nitish
    Gulati, Harmandeep Kaur
    Sharma, Aakriti
    Heer, Shilpa
    Jassal, Anupmjot Kaur
    Arora, Lovenish
    Kaur, Simranpreet
    Singh, Atamjit
    Bhagat, Kavita
    Kaur, Arshmeet
    Singh, Harbinder
    Singh, Jatinder Vir
    Bedi, Preet Mohinder Singh
    MOLECULAR DIVERSITY, 2021, 25 (01) : 603 - 624
  • [9] Dual targeting of estrogen receptor α and estrogen-related receptor α: a novel endocrine therapy for endometrial cancer
    Mao, XiaoDan
    Dong, Binhua
    Gao, Min
    Ruan, GuanYu
    Huang, MeiMei
    Braicu, Elena Loana
    Sehouli, Jalid
    Sun, PengMing
    ONCOTARGETS AND THERAPY, 2019, 12 : 6757 - 6767
  • [10] The role of the tumor microenvironment in endocrine therapy resistance in hormone receptor-positive breast cancer
    Yuan, Jie
    Yang, Li
    Li, Zhi
    Zhang, Hua
    Wang, Qun
    Huang, Jun
    Wang, Bei
    Mohan, Chakrabhavi Dhananjaya
    Sethi, Gautam
    Wang, Geng
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
12345